FDA says it doesn't need a "negative monograph" for cannabis; Republican Party of Texas puts cannabis decriminalization into platform; Chuck Schumer introduces bill in US Senate to decriminalize cannabis and give control to states; Senate Appropriations Committee criticizes Jeff Sessions for blocking research.
Joshua Lee wonders about cause and effect in the deconstructed mind, notes Vanilla Kush's suitability for treating pain or tension-caused insomnia, and finds Trap Star relaxing but not as sleep-inducing.
Senate Appropriations Committee votes to table bill that would allow dispensaries to use banks, Medical Cannabis Advisory Board cancels meeting because it doesn't have enough members and a judge ruled that a penalty meted out to Ultra Health by the DOH was too severe.
The cannabis industry is riding a tremendous wave that rolls onward and swells upward, propelled forward by the remarkable successes of those states brave enough to start the ripple. The benefits universally reaped in legalized states are forcing even the most stubborn skeptics of legalization to reconsider their stance in the face of what has become a true force of nature.
Every gubernatorial candidate but Apodaca seems to have trouble perusing the growing body of research and data pertaining to the positive effects cannabis has had on the states where it's legal, but the constant refrain of “need more research” means they must be missing a few studies here and there.